1) bioreductive drugs
生物还原性药物
2) bioreductive drugs
生物还原活性物
1.
Cytochrome P-450participated in the reduction of bioreductive drugs(including TMQ,AQ4N).
细胞色素P-450参与了生物还原活性物TMQ、AQ4N在机体内的还原。
3) Bio-reductive antitumor drugs
生物还原抗肿瘤药物
4) biological reduction
生物还原
1.
The factors affecting biological reduction of sulfate in TiO2 wastewater using sulfate reducing bacteria(SRB) were studied in an anaerobic sequencing batch reactor,and the operating conditions were also researched.
在厌氧序批式反应器中,采用硫酸盐还原菌(SRB)对钛白废水中硫酸盐生物还原的影响因素及厌氧序批式反应器的运行条件进行了研究。
2.
High-purity nano ZnS particles were synthesized using a coupling reaction of biological reduction and chemical precipitation mediated with EDTA(CRBRCP-EDTA process).
生物还原-化学沉淀耦合反应法制备了纳米硫化锌,采用XRD、SEM、TEM、EDS、PL、FTIR等测试手段对产物进行了结构形貌性能表征。
3.
High-purity nano CdS and PbS particles were synthesized using a coupling reaction of biological reduction and chemical precipitation mediated with EDTA referred as CRBRCP-EDTA process.
本文应用生物还原-化学沉淀耦合反应成功制备了高纯纳米硫化镉和硫化铅,EDTA(Ethylene Diamine Tetraacetic Acid)的加入为高浓度金属离子条件下的生物制备提供了保证。
6) Bioreduction
生物还原
1.
Recovery of manganese from waste batteries using microbe and organic waste through bioreduction process;
微生物还原浸出法回收废旧电池粉末中的金属锰
2.
Pd catalyst supported on γ-alumina(nanoparticles)with high dispersion was prepared by bioreduction with Bacillus lichenifoumis(strain R08),which was strong in reducing ability of Pd~(2+).
XPS测定结果表明,室温下R08菌体可将γ-A l2O3载体表面上的Pd2+基本还原为Pd0;生物还原法制得的催化剂的Pd微粒的平均粒径约为5nm。
3.
The transition metal catalysis reduction, hydride reagents reduction, sodium dithionite reduction and bioreduction ware discussed.
综述了近年来α,β-不饱和羰基化合物α,β-碳碳双键和碳氧双键的选择还原研究进展,讨论了过渡金属催化还原、氢化试剂还原、连三亚硫酸钠还原以及生物还原。
补充资料：放射性碘标记的放射性药物
分子式：
CAS号：
性质： 131I是最早用于临床的放射性核素之一。临床上常用的碘标放射性药物有：(1)Nal31I，用于甲状腺显像和甲亢治疗；(2)心肌显像用131I(123I)-CO-长链脂肪酸；(3)脑功能显像用123I(131I)-IMP(N-异丙基对碘安非他命，N-isopropyl-p-iodoamphetamine)，123I(131I)-HIPDM[N，N,N′-trimethyl-N′-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine]；(4)受体显像用123I(131I)标记变体配体，如D1，D2，乙酰胆碱，安定类受体显像剂；(5)用于放射免疫显像和治疗的131I标记抗肿病抗体；(6)肾上腺显像剂131I-6-碘胆固醇、131I-间-碘苄胍等。
CAS号：
性质： 131I是最早用于临床的放射性核素之一。临床上常用的碘标放射性药物有：(1)Nal31I，用于甲状腺显像和甲亢治疗；(2)心肌显像用131I(123I)-CO-长链脂肪酸；(3)脑功能显像用123I(131I)-IMP(N-异丙基对碘安非他命，N-isopropyl-p-iodoamphetamine)，123I(131I)-HIPDM[N，N,N′-trimethyl-N′-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine]；(4)受体显像用123I(131I)标记变体配体，如D1，D2，乙酰胆碱，安定类受体显像剂；(5)用于放射免疫显像和治疗的131I标记抗肿病抗体；(6)肾上腺显像剂131I-6-碘胆固醇、131I-间-碘苄胍等。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条